Shah, Anita http://orcid.org/0000-0002-7846-3115
Solms, Alexander
Garmann, Dirk
Katterle, Yvonne
Avramova, Verzhiniya
Simeonov, Stanislav
Lissitchkov, Toshko
Clinical trials referenced in this document:
Documents that mention this clinical trial
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
https://doi.org/10.1007/s40262-016-0492-2
Funding for this research was provided by:
Bayer Pharma AG, Leverkusen, Germany
Article History
First Online: 22 December 2016
Compliance with Ethical Standards
:
: This study was funded by Bayer Pharma AG, Leverkusen, Germany. Medical writing assistance was provided by Ken Wannemacher, PhD, from Complete Healthcare Communications, LLC (Chadds Ford, PA, USA) and was funded by Bayer. Open access publication of this manuscript was sponsored by Bayer.
: Anita Shah is an employee of Bayer, and Alexander Solms, Dirk Garmann, and Yvonne Katterle are employees of Bayer Pharma AG. Toshko Lissitchkov, Verzhiniya Avramova, and Stanislav Simeonov have received Grant/research support for clinical trial participation from Bayer.
: The procedures performed in this study were in accordance with good clinical practice guidelines and the guiding principles detailed in the Declaration of Helsinki.
: Informed consent was provided by the patients, and the protocol was approved by the site’s independent Ethics Committee/Institutional Review Board (Local Ethics Committee at SHATHD-Sofia, 6, Plovdivsko pole Str., 1756 Sofia, Bulgaria).